[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112015000136A2 - fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento - Google Patents

fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento

Info

Publication number
BR112015000136A2
BR112015000136A2 BR112015000136A BR112015000136A BR112015000136A2 BR 112015000136 A2 BR112015000136 A2 BR 112015000136A2 BR 112015000136 A BR112015000136 A BR 112015000136A BR 112015000136 A BR112015000136 A BR 112015000136A BR 112015000136 A2 BR112015000136 A2 BR 112015000136A2
Authority
BR
Brazil
Prior art keywords
nutrition
dietary fiber
treating
side effect
gastrointestinal side
Prior art date
Application number
BR112015000136A
Other languages
English (en)
Other versions
BR112015000136B1 (pt
Inventor
Johan Joseph Hageman Robert
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BR112015000136A2 publication Critical patent/BR112015000136A2/pt
Publication of BR112015000136B1 publication Critical patent/BR112015000136B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

resumo patente de invenção: "fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento". a presente invenção refere-se a uma fibra alimentar para uso no retardo ou de outro modo redução de um efeito de saciedade de uma nutrição medicinal ou de um medicamento, onde a nutrição medicinal ou medicamento é para administração oral ou gastroentérica por um humano. a invenção refere-se ainda a um método para tratar profilaticamente ou terapeuticamente um humano com necessidade do mesmo, o tratamento compreendendo administrar uma quantidade eficaz de uma fibra alimentar, em combinação com uma composição farmacêutica ou uma nutrição conforme definido em qualquer uma das reivindicações anteriores, desta maneira reduzindo um efeito de saciedade da composição farmacêutica ou da nutrição. a invenção refere-se ainda a produtos adequados para uso em tal método.
BR112015000136-0A 2012-07-05 2013-07-05 fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento BR112015000136B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2012/050483 WO2014007606A1 (en) 2012-07-05 2012-07-05 Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
NLPCT/NL2012/050483 2012-07-05
PCT/NL2013/050506 WO2014007635A1 (en) 2012-07-05 2013-07-05 Dietary fibre for use in the treatment of a gastro-intestinal side-effect of a nutrition or medicament

Publications (2)

Publication Number Publication Date
BR112015000136A2 true BR112015000136A2 (pt) 2017-06-27
BR112015000136B1 BR112015000136B1 (pt) 2021-01-19

Family

ID=48833037

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112015000136-0A BR112015000136B1 (pt) 2012-07-05 2013-07-05 fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento
BR112014033102A BR112014033102A2 (pt) 2012-07-05 2013-07-05 produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112014033102A BR112014033102A2 (pt) 2012-07-05 2013-07-05 produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido

Country Status (6)

Country Link
US (2) US20150182579A1 (pt)
EP (2) EP2869718A1 (pt)
CN (2) CN104812254B (pt)
BR (2) BR112015000136B1 (pt)
RU (2) RU2637133C2 (pt)
WO (3) WO2014007606A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192180B2 (en) * 2010-09-15 2015-11-24 Paul Raymond Reising Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same
WO2013139861A1 (en) 2012-03-20 2013-09-26 Luc Montagnier Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
KR20180012254A (ko) 2015-04-10 2018-02-05 코멧 바이오리파이닝 인코포레이티드 셀룰로스 바이오매스의 처리를 위한 방법 및 조성물 및 이에 의해 생성된 생성물
AU2016319221B2 (en) * 2015-09-10 2022-06-30 Université Catholique de Louvain Use of pasteurized Akkermansia for treating metabolic disorders
GB201602410D0 (en) 2016-02-10 2016-03-23 Tate & Lyle Ingredients Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates
US10901945B2 (en) 2016-01-05 2021-01-26 The grät Network, PBC Systems and methods concerning tracking models for digital interactions
CN106234922A (zh) * 2016-06-29 2016-12-21 完美（中国）有限公司 谷物纤维粉组合物及其用途
US20180042274A1 (en) * 2016-08-09 2018-02-15 Christopher Bratt Protein Supplement System
US20180200285A1 (en) * 2017-01-13 2018-07-19 Access Business Group International Llc Dietary prebiotic supplement and related method
DE102017201713A1 (de) * 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
US11235019B2 (en) * 2017-04-12 2022-02-01 Artesa Llc Compositions and methods for treating traveler's diarrhea
DK3398692T3 (da) * 2017-05-05 2020-03-23 Dmk Deutsches Milchkontor Gmbh Fremgangsmåde til fremstilling af pastøse levnedsmidler med formindsket udskillelse af deri indeholdte væsker
TWI783043B (zh) 2017-10-25 2022-11-11 日商三菱瓦斯化學股份有限公司 吡咯并喹啉醌的可溶化促進劑、包含其的組成物及可溶化促進方法
WO2019168002A1 (ja) * 2018-02-28 2019-09-06 大塚製薬株式会社 冷菓用組成物
JP7351856B2 (ja) 2018-05-10 2023-09-27 コメット バイオリファイニング インコーポレイテッド グルコース及びヘミセルロースを含む組成物並びにその使用
JP7327395B2 (ja) * 2018-06-05 2023-08-16 三菱瓦斯化学株式会社 飲料、飲料の製造方法又は組み合わせ
WO2021105338A1 (en) * 2019-11-27 2021-06-03 Société des Produits Nestlé S.A. Novel composition for reducing stress disorders
JP7577834B2 (ja) * 2020-08-26 2024-11-05 アボカ エッセ．ピ．ア．ソシエタ アグリコラ メタボリックシンドロームの治療に使用するための新たな特性を有する新規の系
CN113262236B (zh) * 2021-03-25 2022-08-16 暨南大学 一种酚酸酯类化合物的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475861A (en) * 1976-03-19 1977-06-10 Warner Lambert Co Pharmaceutical composition
DE3541945A1 (de) 1985-11-27 1987-06-04 Lomapharm Rudolf Lohman Gmbh K Immunstimulierend wirkende polysaccharide aus zellkulturen von echinacea purpurea (l.) moench und echinacea angustifolia, d.c. verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
FR2657013B1 (fr) 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.
DE69738292T2 (de) 1996-02-09 2008-09-18 Société des Produits Nestlé S.A. Nahrungszusammensetzung für sport
WO1999055174A1 (fr) * 1998-04-23 1999-11-04 Pro Dietic Rdp (S.A.R.L.) Complement proteique, composition alimentaire le contenant, leur procede de preparation et leur utilisation
ES2187115T3 (es) * 1999-01-20 2003-05-16 Nutricia Nv Preparado para lactantes.
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
WO2001082935A1 (fr) * 2000-04-28 2001-11-08 Orient Cancer Therapy Co.,Ltd. Remedes contre le cancer
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
EP1228707A1 (en) 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
JP5294559B2 (ja) 2003-07-03 2013-09-18 スキャンポ・アーゲー クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
DE602004016385D1 (de) * 2003-12-24 2008-10-16 Nutricia Nv Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
DK1737304T3 (da) * 2004-04-09 2014-07-28 Nutricia Nv Flydende koncentreret formel
US20060040003A1 (en) * 2004-08-10 2006-02-23 Alvin Needleman Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free
WO2006102350A1 (en) 2005-03-23 2006-09-28 Washington University In St. Louis The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
FR2884422B1 (fr) * 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
WO2007070454A2 (en) * 2005-12-09 2007-06-21 Novalife High protein supplement
US20090252839A1 (en) * 2005-12-12 2009-10-08 Georg Achterkamp Concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising particulates and xanthan and locust bean gum
ZA200805905B (en) * 2005-12-16 2009-10-28 Nutricia Nv Use of soluble dietary fibres against muscle wasting
JP2008054505A (ja) * 2006-08-29 2008-03-13 Gts Associates:Kk 飼料補助材
KR20080049330A (ko) 2006-11-30 2008-06-04 (주)아모레퍼시픽 포만감을 증가시키는 식품 조성물
CN1969674A (zh) * 2006-11-30 2007-05-30 吴江中怡实业有限公司 食品添加剂
WO2008115046A1 (en) * 2007-03-22 2008-09-25 N.V. Nutricia Cereal-based infant nutrition with fibre
WO2009075564A1 (en) 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
CN101194678B (zh) * 2007-12-17 2011-11-30 余凤娣 一种羊用保健饲料
US8536199B2 (en) * 2008-03-25 2013-09-17 Sarah Steinberg Greenwald Oral combination of vitamins
CN102439048B (zh) * 2009-05-07 2015-03-25 泰莱配料法国有限公司 组合物及制备α-(1,2)-支化的α-(1,6)葡聚寡糖的方法
WO2010147456A1 (en) 2009-06-19 2010-12-23 N.V. Nutricia Inhibition of nfk-b mediated virus replication with specific oligosaccharides
CN101987090A (zh) * 2009-08-07 2011-03-23 上海秀新臣邦医药科技有限公司 氟西汀胶囊及其制备方法
US9192179B2 (en) 2009-11-12 2015-11-24 Nestec S.A. Methods for promoting gut microbiota balance
WO2011152707A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Stable high lipid liquid formula
CN101911974A (zh) * 2010-08-20 2010-12-15 浙江李子园牛奶食品有限公司 开胃消食乳酸菌饮料
CA2713465A1 (en) * 2010-08-24 2012-02-24 Susan P. Hudson Protein-bound tryptophan food composition
WO2012092082A1 (en) 2010-12-30 2012-07-05 Abbott Laboratories Reduced buffering capacity of a low calorie infant formula
CN102488012B (zh) * 2011-12-14 2015-01-28 北京东方联鸣科技发展有限公司 犊牛配方奶粉
CN102423075B (zh) * 2011-12-21 2013-03-20 福建农林大学 一种保健魔芋元宵及其制备方法
CN102599431A (zh) * 2012-04-16 2012-07-25 安徽同福食品有限责任公司 五谷纤维粥及其制备方法

Also Published As

Publication number Publication date
RU2015103719A (ru) 2016-08-27
RU2015103723A (ru) 2016-08-27
CN104684417A (zh) 2015-06-03
US9795628B2 (en) 2017-10-24
WO2014007636A1 (en) 2014-01-09
RU2657530C2 (ru) 2018-06-14
BR112014033102A2 (pt) 2017-06-27
EP2869718A1 (en) 2015-05-13
EP2869719A1 (en) 2015-05-13
BR112015000136B1 (pt) 2021-01-19
CN104812254B (zh) 2018-08-31
US20150272982A1 (en) 2015-10-01
WO2014007606A1 (en) 2014-01-09
RU2637133C2 (ru) 2017-11-30
US20150182579A1 (en) 2015-07-02
CN104812254A (zh) 2015-07-29
WO2014007635A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
BR112015000136A2 (pt) fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
BR112017006957A2 (pt) formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
PH12014502058A1 (en) Pharmaceutical composition comprising empagliflozin and antiobesity drug
BR112014031394A2 (pt) composições e métodos para absorção transmucosa
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112015003590A8 (pt) Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
BR112013000190A2 (pt) formas de dosagem de retenção gástrica compreendendo um análogo de gaba e um opioide
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
MX2016010899A (es) A22k, desb27, b29r, des b30 en la posicion epsilon del analogo de insulina humana acilada de lisina 22.
BR112012000862A8 (pt) composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento
BR112012027092A2 (pt) métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal
BR112016021985A8 (pt) formulação farmacêutica e composto
MX2018002223A (es) Derivados de insulina novedosos y usos medicos de los mismos.
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
WO2012142615A3 (en) Auranofin and auranofin analogs useful to treat proliferative disease and disorders
CO7101244A2 (es) Fenilimidazopirazoles sustituidos y su uso
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23L 1/305 , A23L 1/308 , A23L 1/30 , A61K 31/405 , A61K 31/702 , A61K 31/715 , A61K 31/736 , A61P 1/14

Ipc: A23L 33/10 (2016.01), A23L 33/175 (2016.01), A23L

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/07/2013, OBSERVADAS AS CONDICOES LEGAIS.